EUCTR2019-004496-39-NL进行中（未招募）1 期
A Long-term Follow-up Study to Evaluate the Safety and Efficacy of RGX-501
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •To be eligible to participate in this study, a participant must have
- •previously received RGX-501 in a separate parent trial, and the
- •participant or participant's legal guardian(s) is/(are) willing and able to
- •provide written, signed informed consent after the nature of the study
- •has been explained, prior to any research-related procedures.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 12
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
A long-term follow-up study to evaluate the safety and efficacy of retinal gene therapy in subjects with Choroideremia previously treated with AAV2-REP1 and in subjects with X-Linked Retinitis Pigmentosa previously treated with AAV8-RPGR in an antecedent studyEUCTR2017-003104-42-DEightstaRx Ltd (A Biogen Company)330
进行中（未招募）
1 期
A long-term follow-up study to evaluate the safety and efficacy of retinal gene therapy in subjects with Choroideremia previously treated with AAV2- REP1 in an antecedent study and in subjects with X-Linked Retinitis Pigmentosa previously treated with AAV8-RPGR in an antecedent studyChoroideremia (CHM)X-Linked Retinitis Pigmentosa (XLRP)MedDRA version: 20.1Level: LLTClassification code 10008791Term: ChoroideremiaSystem Organ Class: 100000004853MedDRA version: 20.0Level: PTClassification code 10038914Term: Retinitis pigmentosaSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2017-003104-42-DKightstaRx Ltd (A Biogen Company)330
进行中（未招募）
1 期
A long-term follow-up study to evaluate the safety and efficacy of retinal gene therapy in subjects with Choroideremia previously treated in an antecedent studyChoroideremia (CHM)EUCTR2017-003104-42-NLightstaRx Ltd167
尚未招募
3 期
A Long-term Follow-up Study to Evaluate the Safety and Efficacy of Retinal Gene Therapy in Subjects with Choroideremia Previously Treated with Adeno-Associated Viral Vector Encoding Rab Escort Protein-1 (AAV2-REP1)
and in Subjects with X-Linked Retinitis Pigmentosa Previously Treated with Adeno-Associated Viral Vector Encoding RPGR (AAV8-RPGR) in an Antecedent Study2023-507994-16-00Biogen Idec Research Limited54
已完成
2 期
A Long-term Follow-up Study to Evaluate the Safety and Efficacy of RGX-501familial hypercholesterolaemia10013317NL-OMON49424REGENXBIO Inc2